Both in Pharmaceuticals
Axsome Therapeutics vs Rhythm Pharmaceuticals
Over the past year AXSM returned +2.8% and RYTM returned −24.0%; their daily moves had a correlation of 0.34.
AXSM +2.8% RYTM −24.0%Growth of $1, one year, split-adjusted
| Metric | AXSM | RYTM |
|---|---|---|
| Price | $139.61 | $86.44 |
| Market cap | $7.31B | $5.95B |
| Today | +2.65% | −7.49% |
| 1 month | −21.2% | −6.5% |
| 6 months | −37.4% | −6.4% |
| Year to date | −23.6% | −19.2% |
| 1 year | +3.4% | −24.0% |
| Revenue growth (YoY) | +51.9% | +46.9% |
| Gross margin | 93.1% | 87.5% |
| Net margin | −5.0% | −70.7% |
| P/E (TTM) | — | — |
| Price / sales | 8.5× | 24.8× |
| Net cash | $116.6M | $224.8M |
| Dividend yield | — | — |
| Volatility (60d) | 38.1% | 34.4% |
| Short % of float | 7.6% | 17.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).